ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,659.69
0.26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) News

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FOLD
DateTimeSourceHeadlineSymbolCompany
09/05/202421:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FOLDAmicus Therapeutics Inc
09/05/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
09/05/202412:00GlobeNewswire Inc.Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
08/05/202412:00GlobeNewswire Inc.Amicus Therapeutics to Present at the Bank of America 2024 Health Care ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
01/05/202412:00GlobeNewswire Inc.Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:FOLDAmicus Therapeutics Inc
20/03/202411:00GlobeNewswire Inc.Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) ReportNASDAQ:FOLDAmicus Therapeutics Inc
11/03/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
06/03/202422:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202422:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202422:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202421:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
04/03/202422:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202421:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202421:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202412:00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024NASDAQ:FOLDAmicus Therapeutics Inc
28/02/202412:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
28/02/202412:00GlobeNewswire Inc.Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
20/02/202422:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
20/02/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
20/02/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202412:00GlobeNewswire Inc.Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202421:38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202421:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202414:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
08/02/202421:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
08/02/202412:00GlobeNewswire Inc.Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™NASDAQ:FOLDAmicus Therapeutics Inc
06/02/202421:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FOLD

Your Recent History

LSE
JCH
Jpmorgan Claverhouse Inv...
BIT
UC46C8
Unicredit Bank
LSE
QC44
Citi Fun 25
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved